BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20230312T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20231105T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20240310T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20241103T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20250309T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20251102T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Istanbul
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
TZNAME:+03
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240313T090000
DTEND;TZID=America/New_York:20240313T100000
DTSTAMP:20240306T193945Z
CREATED:20240306T193721Z
LAST-MODIFIED:20240306T193945Z
UID:60515-1710320400-1710324000@globalbiodefense.com
SUMMARY:FMD Vaccine Availability in Africa and Prospects for Improved FMD Control
DESCRIPTION:Join the Global Foot-and-Mouth Disease Research Alliance (GFRA) for their Research Webinar series with Professor Baptise Dungu on 13 March 2024. \nProfessor Dungu will present on the status of FMD vaccine availability in Africa and prospects for improved FMD control through vaccination. \nThis 1-hour webinar will feature Professor Dungu’s 30-minute presentation followed by a 30-minute moderated Q&A session. \nThis series of research webinars presented by the GFRA is inspired by our networking philosophy. This online event series contributes to the continuous professional development of stakeholders at the cutting edge of new ideas and developments in Foot-and-Mouth Disease research. \nThere is no charge for this webinar but registration is required.
URL:https://globalbiodefense.com/event/fmd-vaccine-availability-in-africa-and-prospects-for-improved-fmd-control/
LOCATION:https://crdfglobal.zoom.us/webinar/register/WN_utw1EgMLQFWO5nOgnLP6RQ#/registration
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240314T120000
DTEND;TZID=America/New_York:20240314T130000
DTSTAMP:20240214T233849Z
CREATED:20240214T190847Z
LAST-MODIFIED:20240214T233849Z
UID:59970-1710417600-1710421200@globalbiodefense.com
SUMMARY:GMU Schar School Master of Biodefense Information Session
DESCRIPTION:The George Mason University (GMU) Schar School of Policy and Government will be hosting a Master of Biodefense Information Session on Thursday\, March 14\, noon to 1:00 p.m. ET (Virtual). \nProspective students are invited to attend to hear more about the Master of Biodefense program offered at the Schar School of Policy and Government at George Mason University. \nLearn more about the program\, application process\, student experience\, and graduate outcomes. The program is offered in part-time\, full-time\, online\, in-person\, and hybrid formats. \n Learn more and register for the information session. \nGlobal Biodefense is an official media partner of the GMU Schar School of Policy and Government.
URL:https://globalbiodefense.com/event/gmu-schar-school-master-of-biodefense-information-session/
LOCATION:
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2024/02/gmu-schar-school-ms-biodefense-1200.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20240315T100000
DTEND;TZID=America/Los_Angeles:20240315T110000
DTSTAMP:20240301T221921Z
CREATED:20240301T221921Z
LAST-MODIFIED:20240301T221921Z
UID:60491-1710496800-1710500400@globalbiodefense.com
SUMMARY:Introduction to the 2024 Joint Commission Standards for Infection Control
DESCRIPTION:Beginning this summer\, hospitals looking to maintain or apply for accreditation from The Joint Commission—the nation’s oldest and largest standards-setting and accrediting body in health care—will have to adopt a new set of standards for high-consequence infectious diseases (HCID). \nJoin NETEC for an exploration of the new infection control requirements established by the Joint Commission\, the nation’s oldest and largest standards-setting and accrediting body in health care. Panelists will review key changes to the standards\, which will go into effect July 1\, 2024\, and identify strategies for implementation and compliance. Resources and tools will be shared to empower your organization to help prepare for the new standards by July 2024. \nThis webinar is for health care professionals who will implement and/or provide training on these new standards including\, quality improvement teams​\, emergency managers\, infection preventionists\, hospital epidemiologists\, educational specialists\, nurse educators\, and coordinators for physician education. \nThe webinar is free and open to all health care professionals\, especially quality improvement teams\, emergency managers\, infection preventionists\, hospital epidemiologists\, educational specialists\, nurse educators\, and coordinators for physician education. \nPlease visit NETEC’s Introduction to the 2024 Joint Commission Standards for Infection Control to register. \nNETEC is a collaborative effort of 13 U.S. Regional Emerging Special Pathogen Treatment Centers (RESPTCs) working together to enhance the capacity of the U.S. public health and health care systems to manage special pathogens safely and effectively. Visit the NETEC website to access a wide range of special pathogen resources\, request free readiness consulting and assessment\, or ask your questions related to special pathogens readiness\, response\, or patient care.
URL:https://globalbiodefense.com/event/introduction-to-the-2024-joint-commission-standards-for-infection-control/
LOCATION:MD
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20240315T143000
DTEND;TZID=Europe/Paris:20240315T160000
DTSTAMP:20240306T225301Z
CREATED:20240306T223149Z
LAST-MODIFIED:20240306T225301Z
UID:60528-1710513000-1710518400@globalbiodefense.com
SUMMARY:COMBINE Webinar on Developing Target Product Profiles for Antibiotics
DESCRIPTION:The AMR Accelerator programme will host a COMBINE Webinar on Developing Target Product Profiles for Antibiotics on 15 March 2024. \nDecisions on disease targets and whether to aim for oral or intravenous administration of a new compound requires complex decisions\, involving the desires\, needs and expectations of patients\, healthcare organisations and regulators across the globe. \nDeveloping Target Product Profiles (TPP) is a challenge for antibiotics development. In this webinar\, speakers from CARB-X\, Evotec and GSK will discuss TPPs in relation to aims\, timing\, scope and flexibility. The discussion will discuss the need for TPPs across the development life-cycle: from drug discovery to clinical trials\, taking into account both clinical pathways\, the area of application and market considerations. \nPlease visit the COMBINE Webinar on Developing Target Product Profiles for Antibiotics event page for more information.
URL:https://globalbiodefense.com/event/combine-webinar-on-developing-target-product-profiles-for-antibiotics/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240317
DTEND;VALUE=DATE:20240323
DTSTAMP:20240306T224549Z
CREATED:20240306T224549Z
LAST-MODIFIED:20240306T224549Z
UID:60531-1710633600-1711151999@globalbiodefense.com
SUMMARY:Innovative Approaches in Antibacterial Research and Development to Fight the Antibiotic Resistance Crisis
DESCRIPTION:Innovative Approaches in Antibacterial Research and Development to Fight the Antibiotic Resistance Crisis will take place 17-22 March 2024 in Ventura\, CA. \nThe antibiotic resistance crisis is among us\, and with it\, the urgent need to tackle this global health threat has never been greater. Yet each step in the discovery and development process\, from target validation and inhibitor optimization to clinical trial design and product commercialization\, poses formidable challenges. The New Antibacterial Discovery and Development GCR will turn these challenges into opportunities to promote interdisciplinary innovation while addressing the global need for more effective antibiotic therapies. \nThe conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide\, concentrating on the latest developments in the field. \nHighlighted sessions include: \n\nDiscovering Mechanistically Novel Antibacterial Leads through Phenotypic Screening\nAntisense Antibiotics as Precision Therapeutics for Pseudomonas aeruginosa\nAddressing Antimicrobial Resistance in Clostridioides difficile: Clinical Implications and the Motivation for Novel Treatment Approaches\nBiasing Bacteriophage Behaviours\nAntibiotics Preorganized for Ribosomal Binding Overcome Antimicrobial Resistance\nHost Directed Therapy Against Mycobacterial Infections\nGARDP: Working Globally to Address the Antimicrobial Resistance Crisis\nBeta-lactamases and Skaters: Pairs and Singles\nDevelopment of Broad-Spectrum MBL Inhibitors\nSystems Chemical Biology Approach to Antibiotic Discovery\nMacrocyclic Peptides Disassemble the Periplasmic LPS Transport Bridge: New Approaches to Kill Multidrug-Resistant Gram-Negative Bacteria\nCracking Nature’s Recipes to Design Lipid-Targeting Antibiotics\nChallenges of Antibacterial Discovery\nGenerative Artificial Intelligence for Antibiotic Discovery\nMulti-Drug Resistant (MDR) Pathogens Are Driving the Need for New Novel Antibacterials\nReviving Natural Products Antibiotic Discovery\n\nPlease visit the Gordon Research Conference’s Innovative Approaches in Antibacterial Research and Development to Fight the Antibiotic Resistance Crisis website for more information.
URL:https://globalbiodefense.com/event/innovative-approaches-in-antibacterial-research-and-development-to-fight-the-antibiotic-resistance-crisis/
LOCATION:Ventura Beach Marriott\, 2055 Harbor Boulevard\, 2055 E Harbor Blvd\,\, CA\, 93001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240319
DTEND;VALUE=DATE:20240322
DTSTAMP:20240126T220904Z
CREATED:20240126T220646Z
LAST-MODIFIED:20240126T220904Z
UID:59709-1710806400-1711065599@globalbiodefense.com
SUMMARY:2024 CBRNE Research & Innovation Conference
DESCRIPTION:The 2024 CBRNE Research & Innovation International Conference will take place 19-21 March\, 2024 in Strasbourg\, France. \nCBRNE R&I 2024 will gather stakeholders to discuss topics of CBRNE detection\, protection\, decontamination\, depollution\, medical countermeasures\, diagnostic tools\, epidemiology\, forensic sciences\, and risks & crisis management. Demonstrations are planned from the French & German Committee (including responders from the Fire Brigades\, Emergency Medical Services\, Police\, Gendarmerie\, bomb disposal experts) and scientists from the University of Strasbourg. \nHighlighted workshops and sessions include: \n\nTools to inform health personnel on the detection of highly contagious patients\nBiotoxins analysis (overview of the different exercises on this topic\, discussion on the detection and identification method used by the participants of the round-table for on-site and off-site analysis\, identify the gaps/needs\, future works)\nOn-site chemical detection : crossing the methods and tools to identify solids and liquids\nGas and liquid effluents from lithium batteries : risks assessment\nPersonal decontamination\nProtection: Are current test methods appropriate for evaluating protective clothing?\nDrug detection: detection and training issues\nManagement of accidental pollutions and their consequences\nThe action of canine teams in the face of the CBRNe threats\nTox COM : gestural communication in the warm zone\nCBRN training in a virtual environment\nPediatric CBRNE casualty care considerations\nUse of new technologies in the CBRNe threat assessment : robots and drones\nOn-site radiological detection : limitations and innovations\nEducation on human factors to improve the reliability of operations\n\nPlease visit the 2024 CBRNE Research & Innovation International Conference website for more information and to register.
URL:https://globalbiodefense.com/event/2024-cbrne-research-innovation-conference/
LOCATION:Palais de la Musique & des Congrès\, Palais des Congrès\, Pl. de Bordeaux\, Strasbourg\, 67000\, France
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240319
DTEND;VALUE=DATE:20240322
DTSTAMP:20240206T191913Z
CREATED:20240206T191817Z
LAST-MODIFIED:20240206T191913Z
UID:59923-1710806400-1711065599@globalbiodefense.com
SUMMARY:Bioprocessing Summit Europe 2024
DESCRIPTION:The 7th Annual Bioprocessing Summit Europe will be held 19-21 March 2024 in Barcelona\, Spain and through online participation. \nHighlighted sessions and seminars include: \n\nWhat Have Monoclonal Antibodies Ever Done for Us? Past\, Present\, and Future Perspectives on Antibodies and How They Have Driven Bioprocessing Progress\nLab-on-a-Chip and Microfluidic Technologies in Nanomedicine\nA Universal Tool for Stability Predictions of Biotherapeutics\, Vaccines\, and in vitro Diagnostic Products\nHost Cell Protein Monitoring in AAV-Based Gene Therapy Products Using LC-MS/MS\nThe Technical Challenges of Developing Monoclonal Antibodies against Snake Venoms\npH-Independent Potential-Controlled Antibody Purification\nDesign and Discovery of Affinity and Mixed-Mode Adsorbents\nNovel Approaches in an Efficient Affinity Chromatography Strategy for Your Antibody Variants & Recombinant Proteins\nPredicting and Increasing the Long-Term Stability of Lyophilised mAb Solutions Based on Water Activity\n3D-Printed Devices for Biopurifications\nTowards Continuous Bioproduction—Integration of Microfluidic Systems into Small-Scale Bioreactors\nUpstream Modelling Toolbox for Monoclonal Antibody (mAb) Process Development\nManufacturing Strategy for Recombinant Proteins Expressed in Microbials\nEvaluating Analytical Strategies to Quantify Capsid Titre: Towards a Platform-Method Approach to Accelerate AAV Drug Product Development\nAccelerating AAV process development and release testing with a walk-away immunoassay platform\n\nPlease visit Cambridge Healthtech Institute’s Bioprocessing Summit Europe 2024 website for more information and to register.
URL:https://globalbiodefense.com/event/bioprocessing-summit-europe-2024/
LOCATION:Intercontinental Barcelona\, Av. de Rius i Taulet 3\, Barcelona\, 08004\, Spain
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240321
DTEND;VALUE=DATE:20240324
DTSTAMP:20240126T213623Z
CREATED:20230908T140853Z
LAST-MODIFIED:20240126T213623Z
UID:59069-1710979200-1711238399@globalbiodefense.com
SUMMARY:ASPPH 2024 Annual Meeting
DESCRIPTION:The 2024 ASPPH Annual Meeting for Academic Public Health is March 21-23\, 2024 in Arlington\, Virginia. \nThe Annual Meeting convenes graduate and undergraduate academic public health leaders\, faculty\, students\, and members of the public health community from around the world to research in public health. We are committed to presenting timely\, relevant sessions and information and facilitating essential discussions that advance our shared mission of creating a healthier world. \nNetwork with academic public health leaders\, students\, and faculty; public health partners from the government; fellow association members; and foundation leaders and sponsors of academic public health initiatives. \nThe meeting will be held all day on Thursday\, March 21 and Friday\, March 22 with optional skill-building workshops on Saturday\, March 23 from 8:00 AM – 11:00 AM ET. \nTaking place Friday\, March 22 at 9:00 AM ET\, Dr. Lisa Cooper\, Bloomberg Distinguished Professor\, Johns Hopkins Bloomberg School of Public Health\, and author of Why Are Health Disparities Everyone’s Problem\, will provide opening remarks. An inter-sectoral panel discussion will follow with representatives from academia\, government\, and industry discussing the role of their respective disciplines in advancing knowledge and understanding of health disparities and identifying mechanisms to improve minority health and reduce health disparities. This session aims to foster a deeper understanding of the challenges at hand and inspire collaborative solutions. \nPlease visit the 2024 ASPPH Annual Meeting website for more information.
URL:https://globalbiodefense.com/event/aspph-2024-annual-meeting/
LOCATION:Crystal Gateway Marriott\, 1700 Jefferson Davis Highway\, Arlington\, VA\, 22202\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240324
DTEND;VALUE=DATE:20240325
DTSTAMP:20240206T190625Z
CREATED:20240206T190625Z
LAST-MODIFIED:20240206T190625Z
UID:59891-1711238400-1711324799@globalbiodefense.com
SUMMARY:Radiological and Nuclear Preparedness and Response Workshop
DESCRIPTION:NACCHO\, in collaboration with the Centers for Disease Control and Prevention (CDC) and other state and local partners\, is hosting a full day  radiological/nuclear preparedness and response workshop for about 70 attendances on 24 March 2024 in Cleveland\, Ohio. \nThis is a pre-conference workshop prior to NACCHO’s Preparedness Summit\, taking place 25-28 March 2024. The Preparedness Summit is a one-of-a-kind learning and networking opportunity for local health officials and their public health partners from all geographic regions of the nation to share perspectives and engage in dialogue on common key public health practice issues. \nThis interactive workshop’s first aim is to offer justification for why robust radiation planning and exercising are essential while also providing resources currently used by emergency and public health planners to bridge knowledge gaps and improve their existing radiation planning and exercising programs. The second aim of the workshop is to introduce and train public health preparedness planners to facilitate a new CDC tool called TEST (Training and Exercise Simulation Tool) which is a collaborative serious game that was developed to bridge the gap between discussion and operational exercises for Community Reception Centers (CRCs) using narrative-based problems to foster teamwork\, resource management and understanding of specific roles and responsibilities during a radiation emergency. \nPlease note that due to funding and space restrictions\, we may not be able to accommodate all requests. We will make every effort to include as many applicants as possible and will ensure a diversity of representation across the country. Your answers to the questions below will assist us in this process. \nInformation gained from this workshop will help inform future NACCHO communications plans and corresponding promotional activities that highlight resources of most need. \nPlease visit NACCHO’s Radiological and Nuclear Preparedness and Response Workshop for more information and to register to attend.
URL:https://globalbiodefense.com/event/radiological-and-nuclear-preparedness-and-response-workshop/
LOCATION:Huntington Convetion Center of Cleveland\, 300 Lakeside Avenue\, Cleveland\, OH\, 44113\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240325
DTEND;VALUE=DATE:20240329
DTSTAMP:20240306T231313Z
CREATED:20240306T231313Z
LAST-MODIFIED:20240306T231313Z
UID:60533-1711324800-1711670399@globalbiodefense.com
SUMMARY:Preparedness Summit 2024
DESCRIPTION:The 2024 Preparedness Summit will be held 25-28 March 2024 in Cleveland\, Ohio. \nJoin more than 2\,500 attendees—who work in all levels of the government (federal\, state\, and local)\, emergency management\, volunteer organizations\, healthcare coalitions\, and academia—to share best practices\, build partnerships\, advance your skills\, and take away innovative solutions and practical strategies to address the vulnerabilities in our country’s health security system. \nHighlighted sessions include: \n\nAdvancing anthrax preparedness: Strengthening national defense against biological threats through cross-agency collaboration\nThe vital role of public health laboratories in response to surge events\nBioterrorism risk communications: Where are we now?\nPediatric concerns in a large-scale\, multi-state chemical\, biological\, radiological\, nuclear\, and explosive (CBRNE) mass casualty incident\nTularemia Emergency Response: Clinical Guidelines for Treatment and Prophylaxis After Intentional Release or Naturally Occurring Outbreaks of Francisella tularensis\nMedical toxicology and public health: A fruitful partnership illustrated by a popular awareness level course on chemical threats\nA National Special Pathogen System (NSPS) of care: Defining and expanding the structure for a more coordinated response to high consequence infectious diseases\nRegulatory framework for medical countermeasures response: Lessons from the expanded access programs for mpox therapeutics\nOperationalizing an early response framework for public health emergencies\nCultivating resilient public-clinical health networks to protect against infectious disease outbreaks\nBringing special pathogen care home: Virtual assessment model for at-home evaluation of suspected high-consequence infectious disease cases\nChaos to Clarity: The Post COVID-19 Transition\nEnhancing public health at the border: Mass vaccination initiatives\nAdvancing equity in mpox and COVID-19 diagnostics: Rapid summary of priority actions\nEnhancing state infectious disease preparedness and response capabilities for future threats via a discovery hub: INSPIRE: Readiness\nCHEMPACK program: Nerve agent antidotes\nPandemic Preparedness Training for Small Businesses\nPreparedness epidemiology: A local perspective\nMaking sense of the system: A One Health-based approach to assessing risk\, prioritizing action\, and building resilience\nWorking with the community to respond to a tripledemic of hepatitis A\, meningococcal disease\, and mpox affecting the same at-risk populations in Orange County\nA Case Study in Collaboration: Public Health\, Healthcare\, and Emergency Management Response to the East Palestine\, Ohio Train Derailment\nAdvancing national all-hazards hospital situational awareness\nFrom sewage to solutions: The possibilities and implications of wastewater monitoring\n\nA pre-conference workshop on Radiological and Nuclear Preparedness and Response will be held on 24 March 2024. \nPlease visit the 2024 Preparedness Summit website for more information and to register to attend.
URL:https://globalbiodefense.com/event/preparedness-summit-2024/
LOCATION:Huntington Convetion Center of Cleveland\, 300 Lakeside Avenue\, Cleveland\, OH\, 44113\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240325
DTEND;VALUE=DATE:20240329
DTSTAMP:20240307T004102Z
CREATED:20240307T004026Z
LAST-MODIFIED:20240307T004102Z
UID:60536-1711324800-1711670399@globalbiodefense.com
SUMMARY:20th Meeting of the Vector Control Advisory Group (VCAG)
DESCRIPTION:The 20th Meeting of the World Health Organization’s Vector Control Advisory Group (VCAG) will be held 25 March 2024 via online participation. \nHighlighted agenda items include: \n\nAedes SIT\nSpatial repellents\nTopical repellents\nVCAG operation\n\nThe sessions are for VCAG members or invitees only. \nAbout the VCAG \nAn independent evaluation of the public health value of innovative new tools\, technologies and approaches for vector control is needed to enable WHO to provide evidence-based advice to Member States on whether their deployment is justified. This is essential to ensure that scarce resources available for disease control are used to maximum impact. In order to assist WHO in developing public health policy on new tools\, the Vector Control Advisory Group (VCAG) assesses the public health value of new interventions and provides guidance on developing the evidence base required to inform such assessments. \nRead the report from the prior meeting of the VCAG in September 2023. \nPlease visit the WHO’s 20th Meeting of the Vector Control Advisory Group (VCAG) page for more information.
URL:https://globalbiodefense.com/event/20th-meeting-of-the-vector-control-advisory-group-vcag/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240326
DTEND;VALUE=DATE:20240329
DTSTAMP:20240206T194536Z
CREATED:20240206T194536Z
LAST-MODIFIED:20240206T194536Z
UID:59929-1711411200-1711670399@globalbiodefense.com
SUMMARY:Precision Med TRI-CON 2024
DESCRIPTION:The 31st International Precision Med TRI-CON 2024 will be held 26-28 March 2024 in San Diego\, California. \nVirtual participation is available as well as flexible registration to switch between in-person and virtual attendance across the conference. \nJoin thousands of international thought leaders to discuss the latest research\, technologies\, innovation and business models in implementing precision medicine\, biomarkers and companion diagnostics\, genomic medicine\, and precision health; innovation and market access strategies for at-home diagnostics\, point-of-care testing and molecular diagnostics for infectious diseases; liquid biopsy and advanced diagnostics for precision oncology\, including Multi-Cancer Early Detection and Minimal Residual Disease testing. \nEmerging implications of faster and cheaper sequencing\, AI and digital tools\, and spatial biology and single-cell multiomics in advancing precision medicine will be covered in 2024. \nHighlighted sessions and topics include: \n\nThe Shifting Landscape of Respiratory Pathogen Testing\nMultiplex Testing for Respiratory Pathogens—What Is the Right Fit?\nControlled Human Infection Models in Biomarker Development for Precision Medicine\nThe Host Response in Acute Infections and Sepsis: Potential Challenges and Benefits\nClinical Metagenomic Sequencing for Rapid Diagnosis of Infections\nDiagnostic Stewardship and Implementation of New Tests for Infectious Diseases in the Emergency Department\nDiagnosis of Invasive Fungal Infections by Microbial Metagenomics Sequencing\nAdvancing the AI in Diagnostics and Healthcare: Role of the Public-Private Partnership Model\nAugmenting AI-Powered Clinician Decision Support Tools for Severe Infection\nClinical Integration of Microbial Whole-Genome Sequencing\nHigh-Resolution Single-Cell and Spatial Technologies in Drug Development\nHome Testing for Infectious Diseases and Chronic Disease Monitoring\nScalable Solutions for Antibody Development and Manufacturing\nAccelerating Patient-Centered Diagnostics by Bringing Innovative Molecular Technologies to Point-of-Care Testing\nAt-Home Blood Microsampling: Innovations\, Opportunities\, and Challenges\nDirect Access Testing—What Can Be Done to Realize Its Full Potential?\nAdvances in Mobile and Digital Technologies for Point-of-Care Diagnostics\nRADically Speeding the Development and Validation of POC and Home-Based Diagnostics at the NIH: Lessons Learned and Future Directions\n\nPlease visit Cambridge Healthtech Institute’s Precision Med TRI-CON 2024 event page for more information and to register.
URL:https://globalbiodefense.com/event/precision-med-tri-con-2024/
LOCATION:Hilton San Diego Bayfront\, 1 Park Boulevard\, San Diego\, CA\, 92101-7897\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240401
DTEND;VALUE=DATE:20240405
DTSTAMP:20240206T233823Z
CREATED:20240206T233823Z
LAST-MODIFIED:20240206T233823Z
UID:59932-1711929600-1712275199@globalbiodefense.com
SUMMARY:World Vaccine Congress Washington 2024
DESCRIPTION:The World Vaccine Congress Washington 2024 will take place 1-4 April in Washington\, D.C. \nFrom basic research to commercial manufacture\, this one meeting covers the​ whole vaccine value chain where science\, government and manufacturers all come together to create ground- breaking progress.​ \nHighlighted sessions and topics include: \n\nGlobal Health mABs\nBiodefense & Preparedness Workshop\nVaccine Technology Workshop\nSpecial populations in clinical trials\nWhat are international agencies and industry doing to promote a One Health approach to global health risks\nAMR Workshop: Role of vaccines\, mABs\, phages and antibiotics\nPreparation of the CEPI Centralized Laboratory Network for Future Outbreaks\nRNA Workshop: From vaccines to therapeutics\nVaccine Delivery Workshop\nBiodegradable Lipid Nanoparticles for mRNA Vaccines with Room Temperature Stability\nInnovating vaccine development and implementation for impact\nSmallpox and Mpox live nonreplicating vaccine\nGlobal Health Workshop (NTDs)\nDeveloping novel partnership model for vaccines in EID\nImmune profiling: Building translational tools to improve mRNA vaccine performance\nVaccine manufacturing insights from Asia: Strengthening vaccine production capacity and capabilities\nChikungunya vaccine candidate\nThe evolving role of the ACIP\nThe future of COVID-19 vaccinations. Should we be developing broadly protective antigens or combinational vaccines?\nMonoclonal antibodies for prophylaxis of infectious disease\nWhat is the burden and uptake for RSV vaccines?\nThe future of global health: How to Advance detection and response capacity for Emerging & Re-emerging Pathogens in Africa & LMICs\nDecentralized trial solutions to improve access and health equity\nEmerging & re-emerging zoonotic diseases: what are our priority pathogens for spill over & pandemic risk?\nStudies to investigate the non-specific effects of vaccines and their importance in HICs and LMICs\nAn agile approach to PBMC collection in Vaccine Trials\nNirsevimab\, a monoclonal antibody for protection of all infants from RSV\n\nPlease visit the World Vaccine Congress Washington 2024 event site for more information and to register.
URL:https://globalbiodefense.com/event/world-vaccine-congress-washington-2024/
LOCATION:Walter E. Washington Convention Center\,  801 Mt Vernon Pl NW\, Washington\, DC\, 20001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240402T130000
DTEND;TZID=America/New_York:20240402T143000
DTSTAMP:20240307T005932Z
CREATED:20240307T005932Z
LAST-MODIFIED:20240307T005932Z
UID:60538-1712062800-1712068200@globalbiodefense.com
SUMMARY:Uncertainty\, Trust\, and the Future of Public Health Communication
DESCRIPTION:A seminar on Uncertainty\, Trust\, and the Future of Public Health Communication will be held on 2 April 2024 online from 1:00-2:30 ET. \nThis program will explore public health communication in the context of a post – acute COVID world. How can we more effectively communicate public health messaging across different populations? What are the consequences of misinformation? How can we mitigate disinformation and disseminate accurate information to promote better health for all? \nThis event is cohosted by the Boston University School of Public Health and the BU College of Communication. \nPlease visit BU School of Public Health’s Uncertainty\, Trust\, and the Future of Public Health Communication to register.
URL:https://globalbiodefense.com/event/uncertainty-trust-and-the-future-of-public-health-communication/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240403
DTEND;VALUE=DATE:20240405
DTSTAMP:20240201T184017Z
CREATED:20240201T183935Z
LAST-MODIFIED:20240201T184017Z
UID:59781-1712102400-1712275199@globalbiodefense.com
SUMMARY:Artificial Intelligence and Automated Laboratories for Biotechnology: Leveraging Opportunities and Mitigating Risks
DESCRIPTION:This public workshop will discuss the use of artificial intelligence (AI) and automated laboratories for biotechnology. \nThe event will be held in-person at the National Academy of Sciences Building in Washington DC from 9:00am-5:00pm over two days (3-4 April 2024). Virtual attendances is available as well. \nThe workshop will consider opportunities to leverage AI and laboratory automation capabilities for discovery and development and opportunities to prevent the misuse of biotechnology. The workshop will also explore methods and approaches to identify\, track\, and forecast the domestic and international development of such technologies. \nThe transdisciplinary event will convene experts across sectors and utilize expertise to highlight recent advances and explore implications for the development and use of these technologies. \nThe workshop is being organized by a planning committee of the National Academies of Sciences\, Engineering\, and Medicine under the auspices of the Standing Committee on Advances and National Security Implications of Transdisciplinary Biotechnology \nWorkshop presentations and discussions will include the following topics: \n\nApplications of AI and automated laboratories for biotechnology discovery and development across various applications\nOpportunities for using AI and automated laboratories to prevent the misuse of biotechnology\nMethodologies and information for forecasting the development of AI and automated laboratory technologies\, and for assessing the technologies’ current and future capability gaps\, including approaches for identifying inaccuracies in science and technology materials that might change such assessments\nDrivers of innovation for AI and automated laboratory technologies\, including technical\, financial\, and policy drivers\nMethodologies for assessing the costs and benefits of investing or not investing in the development and adoption of such technologies for national security\, which could include methods from other fields that can be translated to biotechnology\n\nPlease visit the National Academies’ Artificial Intelligence and Automated Laboratories for Biotechnology: Leveraging Opportunities and Mitigating Risks event page to register.
URL:https://globalbiodefense.com/event/artificial-intelligence-and-automated-laboratories-for-biotechnology-leveraging-opportunities-and-mitigating-risks/
LOCATION:National Academies of Sciences\, 2101 Constitution Ave NW\, Washington\, DC\, 20418\, United States
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2024/02/nasem-artificial-intelligence-automated-labs-biotechnology-risk-reduction.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240403
DTEND;VALUE=DATE:20240405
DTSTAMP:20240201T205320Z
CREATED:20240201T200727Z
LAST-MODIFIED:20240201T205320Z
UID:59789-1712102400-1712275199@globalbiodefense.com
SUMMARY:Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions - Fourth Meeting
DESCRIPTION:In response to a Congressional request\, an ad hoc committee of the National Academies of Sciences\, Engineering\, and Medicine is conducting a study on processes for evaluating the safety and efficacy of drugs for rare diseases or conditions in the United States and the European Union. \nThis is the fourth meeting of the committee of experts and will be conducted virtually. The meeting is a closed session and will not include a public session. \nWritten comments from the public may be submitted for the committee’s consideration. \nThe committee will evaluate: \n\nFlexibilities\, authorities\, or mechanisms available to regulators in the United States and the European Union applicable to rare diseases or conditions;\nThe consideration and use of supplemental data submitted during review processes in the United States and the European Union\, including data associated with open label extension studies and expanded access programs specific to rare diseases or conditions;\nAn assessment of collaborative efforts between United States and European Union regulators related to: product development programs under review; policies under development and those recently issued; and scientific information related to product development or regulation.\n\nPlease visit the National Academies’ Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions in the United States and the European Union event page for more information.
URL:https://globalbiodefense.com/event/processes-to-evaluate-the-safety-and-efficacy-of-drugs-for-rare-diseases-or-conditions/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240405T120000
DTEND;TZID=America/New_York:20240405T130000
DTSTAMP:20240318T014909Z
CREATED:20240214T215904Z
LAST-MODIFIED:20240318T014909Z
UID:59973-1712318400-1712322000@globalbiodefense.com
SUMMARY:GMU Schar School Master of Biodefense Information Session
DESCRIPTION:The George Mason University (GMU) Schar School of Policy and Government will be hosting a Master of Biodefense Information Session on Wednesday\, April 5\, noon to 1:00 p.m. ET (Virtual). \nProspective students are invited to attend to hear more about the Master of Biodefense program offered at the Schar School of Policy and Government at George Mason University. \nLearn about the program\, application process\, student experience\, and graduate outcomes. The program is offered in part-time\, full-time\, online\, in-person\, and hybrid formats. \n Learn more and register for the information session. \nGlobal Biodefense is an official media partner of the GMU Schar School of Policy and Government.
URL:https://globalbiodefense.com/event/gmu-schar-school-master-of-biodefense-information-session-2/
LOCATION:
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2024/02/gmu-schar-school-ms-biodefense-1200.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240408
DTEND;VALUE=DATE:20240412
DTSTAMP:20240307T015243Z
CREATED:20240307T015134Z
LAST-MODIFIED:20240307T015243Z
UID:60540-1712534400-1712879999@globalbiodefense.com
SUMMARY:Microbiology Society Annual Conference 2024
DESCRIPTION:The Microbiology Society Annual Conference 2024 will be held 8-11 April 2024 in Edinburgh\, Scotland. \nThe four-day conference consists of scientific symposia\, workshops\, fora\, professional development sessions\, Prize Lectures\, Hot Topics and much more. \nHighlighted sessions include: \n\nA protein-based molecular toolkit to study\, detect\, prevent and treat Oropouche fever\, a neglected tropical viral disease\nPhylodynamic analyses of A(H5N1) highly pathogenic avian influenza viruses reveal reassortment dynamics and diversification of host specificity\nAfrican Swine Fever Virus Multigene Family Interferon Inhibitory Proteins: Functions and Application to Vaccine Development\nUsing Protein Structure Prediction to Map Glycoprotein Diversity Reveals Defining Events in the Evolutionary History of the Flaviviridae\nComprehensive quantitative temporal proteomic\, transcriptomic and effectome analysis of mpox\nUsing serological responses to establish a correlate of protection against Chikungunya virus.\nA Copper Economy Underlies Synergy of Candida albicans and Staphylococcus aureus Dual-Species Biofilms\nZIKV sfRNA production: a tale of two hosts\n‘One Health’ Genomic Surveillance of Avian and Human Influenza A Viruses Through Environmental Wastewater Monitoring\nInfluenza A packaging and protein expression: in silico improvements in molecular characterisation\nEvaluation of virus transmission blockers in an in vivo pig influenza challenge model\nApplying Droplet Fluidics to Mycobacterial Drug Discovery\nDengue virus NS4A modulates NF-κB signalling and viral replication in Aedes aegypti mosquitoes\nA novel strategy to combat Group B Streptococcus neonatal disease by targeting interkingdom interactions with fungus Candida albicans\nAntibiotic resistance alters the ability of Pseudomonas aeruginosa to invade the respiratory microbiome\nInterferon-stimulated gene expression screening reveals genes with candidate antiviral activity against HCoV-OC43\nEpitranscriptomic Regulation of Influenza A Viruses\nZNFX1 is an RNA-regulated E3 ubiquitin ligase involved in antiviral responses\nThe differential antiviral activities of IFITM2/3 against SARS-CoV-2 are regulated by their N-terminal domain\nDetection of alpha and beta coronaviruses in bats in England during 2021-2023\nAssessing serological exposure to H5 avian influenza in humans in Malaysian Borneo\, along the East Asian – Australasian Flyway\n\nPlease visit the Microbiology Society Annual Conference 2024 website for more information.
URL:https://globalbiodefense.com/event/microbiology-society-annual-conference-2024/
LOCATION:Edinburgh International Conference Centre (EICC)\, 150 Morrison Street\, Edinburgh\, EH3 8EE\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240408
DTEND;VALUE=DATE:20240411
DTSTAMP:20240308T191134Z
CREATED:20240308T191050Z
LAST-MODIFIED:20240308T191134Z
UID:60551-1712534400-1712793599@globalbiodefense.com
SUMMARY:BV-BRC Viral Sub-Species Classification Workshop
DESCRIPTION:The Bacterial and Viral Bioinformatics Resource Center (BV-BRC) along with the CDC\, NCBI\, and NIAID\, are hosting a hybrid workshop on viral sub-species classification 8-10 April 2024. \nA critical aspect of the response to the COVID-19 pandemic was to trace\, classify\, and understand the evolving virus lineages\, their phenotypic differences\, and their impact on diagnostics\, vaccines\, and therapeutics. \nClassification and tracing of sub-species level variation has also been similarly important in outbreaks of viruses such as influenza\, HIV\, and monkeypox\, and has informed public health risk assessment and communication strategies. \nTo prepare for the next\, inevitable outbreak of virus disease\, the workshop will review various classification schemes developed for SARS-CoV-2 and other viruses\, examination of the methods and tools developed for classification\, discussion of the utility and impact of classification schemes on the public health response\, and review of lessons learned from past and current outbreaks. \nWorkshop speakers include: \n\nAnderson\, Tavis\, U.S. Department of Agriculture\nBahl\, Justin\, University of Georgia\nDonato\, Celeste\, Monash University\, Murdoch Children’s Research Institute\nHatcher\, Eneida\, National Center for Biotechnology Information\nHinrichs\, Angie\, University of California Santa Cruz\nKorber\, Bette\, Los Alamos National Labs\nKuhn\, Jens\, NIH/NIAID Integrated Research Facility\nLe Mercier\, Philippe\, Swiss-Prot group\, Swiss Institute of Bioinformatics\nLefkowitz\, Elliot\, University of Alabama at Birmingham\nNeher\, Richard\, University of Basel\nNjau\, Emma Peter\, Sokoine University of Agriculture\nRachel Colquhoun\, University of Edinburgh\nRoemer\, Cornelius\, University of Basel\nRota\, Paul\, U.S. Centers of Disease Control and Prevention\nSeto\, Don\, George Mason University\nSimmonds\, Peter\, University of Oxford\nSmith\, Derek J\, University of Cambridge\nWang\, Sean\, Minnesota Department of Health\nWarren\, Andrew\, University of Virginia\nZmasek\, Christian\, J.Craig Venter Institute\n\nThe outcome of the workshop will be to define best practices for establishing sub-species classification systems for these and other viruses that will be important in controlling future out breaks and potential pandemics. The valuable insights and best practices from this workshop will be widely disseminated. \nPlease visit the BV-BRC’s Viral Sub-Species Classification Workshop page for more information.
URL:https://globalbiodefense.com/event/bv-brc-viral-sub-species-classification-workshop/
LOCATION:NIAID Campus Rockville\, 5601 Fishers Lane\, Rockville\, MD\, 20892\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240409
DTEND;VALUE=DATE:20240413
DTSTAMP:20240203T020221Z
CREATED:20240203T020221Z
LAST-MODIFIED:20240203T020221Z
UID:59879-1712620800-1712966399@globalbiodefense.com
SUMMARY:Tropical and Emerging Infectious Diseases for Clinicians and Translational Scientists
DESCRIPTION:The Special Pathogens Excellence in Clinical Treatment\, Readiness\, & Education (SPECTRE) Center for Tropical Diseases (CTD) will host the 2024 Symposium on Tropical and Emerging Infectious Diseases for Clinicians and Translational Scientists from 9-12 April 2024 in Galveston\, Texas. \nThrough collaborative efforts at the University of Texas Medical Branch\, this symposium seeks to engage clinicians\, clinical investigators\, and field and laboratory researchers in discussion of current issues and future challenges in the field of tropical and emerging infectious diseases. The primary goal of this symposium is to foster an environment that facilitates exposure to diverse approaches to combat the emergence and reemergence of infectious diseases. \nPlease visit UTMB Health’s 2024 Symposium on Tropical and Emerging Infectious Diseases for Clinicians and Translational Scientists to register.
URL:https://globalbiodefense.com/event/tropical-and-emerging-infectious-diseases-for-clinicians-and-translational-scientists/
LOCATION:UTMB Health Education Center\, 301 11th St\, Galveston\, TX\, 77550\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240411
DTEND;VALUE=DATE:20240413
DTSTAMP:20240302T211201Z
CREATED:20240302T211201Z
LAST-MODIFIED:20240302T211201Z
UID:60496-1712793600-1712966399@globalbiodefense.com
SUMMARY:NIST Rapid Microbial Testing Methods Consortium Workshop
DESCRIPTION:The NIST-led Rapid Microbial Testing Methods (RMTM) Consortium is hosting the 4th annual workshop 11-12 April 2024 to update the community on RMTM Consortium efforts and to work on Consortium deliverables. \nOver the course of two days\, independent working sessions will be hosted\, with Day 1 open to the public and Day 2 for Consortium members only. \nThis open\, virtual workshop is free of charge. All interested parties are invited to Day 1\, including advanced therapy producers\, rapid microbial testing assay/instrument developers\, and cell reference material producers. \nNew members are being accepted into the Consortium. \nPlease visit NIST’s 2024 NIST Rapid Microbial Testing Methods Consortium Workshop website for more information. \nABOUT THE RMTM \nThe NIST Rapid Microbial Testing Methods (RMTM) Consortium addresses the need for measurements and standards\, including reference materials\, to increase confidence in the use of rapid testing for microbial contaminants in regenerative medicine and advanced therapy products. \nThe safety and quality of advanced therapies\, including cell therapy\, gene therapy\, and tissue engineered products\, must be maintained prior to patient administration. The culture-based compendial methods currently used to assess product purity (specifically to ensure absence of microbial contamination) typically take weeks\, which is inadequate for patients in urgent need of life-saving therapies. These methods are also incompatible with products that have a limited shelf-life and cannot meet good manufacturing practices required in process control and release testing. Alternative rapid microbial testing methods are needed to ensure fit for purpose safety assessments for this broad class of advanced therapeutics. \nThe NIST RMTM Consortium brings together experts across the regenerative medicine field including stakeholders in industry\, academia and government to address this need.
URL:https://globalbiodefense.com/event/nist-rapid-microbial-testing-methods-consortium-workshop/
LOCATION:
CATEGORIES:Government Hosted
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240411
DTEND;VALUE=DATE:20240415
DTSTAMP:20240307T021155Z
CREATED:20240307T021155Z
LAST-MODIFIED:20240307T021155Z
UID:60547-1712793600-1713139199@globalbiodefense.com
SUMMARY:EAP2024 Mastercourse Update on Infectious Diseases in Paediatrics
DESCRIPTION:The European Academy of Paediatrics will host the EAP2024 Mastercourse Update on Infectious Diseases in Paediatrics from 11-14 April in Porto\, Portugal. \nHighlighted sessions and topics include: \n\nNew vaccines and schedules to prevent pneumococcus\nMeningococcus: How best to prevent a moving target?\nThe many faces of Streptococcus pyogenes infection in children\nAssessment of AMPK Levels in Neonates with Suspected Sepsis\nAssessment of the diagnostic accuracy of various Artificial Intelligence platforms\nFever and convulsions in a neonate\nEpidemiology and severity of acute viral respiratory infections in hospitalized children during\nand after the Covid-19 pandemic\nA challenging case of severe pneumonia\nIncrease in paediatric outpatient antibiotic prescribing following marked reductions during the\nCOVID-19 pandemic\nThe febrile neonate – tips to a successful lumbar puncture\nRecurrent skin infections in a child\nAn atypical pleural effusion\n\nPlease visit the EAP2024 Mastercourse Update on Infectious Diseases in Paediatrics site for more information.
URL:https://globalbiodefense.com/event/eap2024-mastercourse-update-on-infectious-diseases-in-paediatrics/
LOCATION:Sheraton Porto\, R. do Ten. Valadim 146\, Porto\, 4100-476\, Portugal
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240411T100000
DTEND;TZID=America/New_York:20240411T110000
DTSTAMP:20240326T223644Z
CREATED:20240326T223529Z
LAST-MODIFIED:20240326T223644Z
UID:60644-1712829600-1712833200@globalbiodefense.com
SUMMARY:Virus-Like Particles: Functionalities in Vaccinology and Research
DESCRIPTION:A webinar on Virus-Like Particles: Functionalities in Vaccinology and Research will be held on 11 April 2024. \nThe event is part of a series of research webinars presented by the Global Foot and Mouth Disease Research Alliance (GFRA). \nAbout the speaker: \nDr. Michael Puckette is a supervisory microbiologist for the Biologics Development Module\, or BDM\, located at the USDA National Bio and Agro-Defense Facility (NBAF). In his role\, Dr. Puckette will focus research on accelerating the technology transfer from research to commercial partners. In his previous role with the Department of Homeland Security-Science & Technology (DHS-S&T)\, Dr. Puckette worked at Plum Island Animal Disease Research Center developing Foot-and-Mouth Disease Virus (FMDV) vaccine technologies. \nPlease visit the Virus-Like Particles: Functionalities in Vaccinology and Research event page for more information.
URL:https://globalbiodefense.com/event/virus-like-particles-functionalities-in-vaccinology-and-research/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240415
DTEND;VALUE=DATE:20240418
DTSTAMP:20240206T235140Z
CREATED:20240206T235140Z
LAST-MODIFIED:20240206T235140Z
UID:59935-1713139200-1713398399@globalbiodefense.com
SUMMARY:Festival of Biologics USA 2024
DESCRIPTION:The Festival of Biologics USA 2024 will be held 15-17 April 2024 in San Diego\, California. \nThe Festival of Biologics aims to bring together senior biologics professionals across the value chain to showcase their research\, collaborate on challenges\, forge new connections and ultimately advance the industry to improve patient health. \nHighlighted sessions and topics include: \n\nTools and technologies advancing biotherapeutic design and development\nThe Landscape of Machine learning and Artificial Intelligence in drug development\nKeynote panel discussion: Engineering Next Generation Therapeutics – the future of antibody development\nAntibody fragments for toxic payload delivery: a platform for radiopharmaceutical therapy of solid tumors\nDevelopment of Checkpoint Agonist Antibodies for Immunological Diseases\nmRNA vaccines to prevent or treat autoimmune disorders: A paradigm shift\nTwo is Better Than One: Integration of in vitro and in vivo Bioanalytical Support by LCMS in the Development of Bispecific Antibodies\nExploring mutation resistant component of SARS-CoV-2 therapeutics\n\nPlease visit Terrapin’s Festival of Biologics USA 2024 website for more information and to register. \n 
URL:https://globalbiodefense.com/event/festival-of-biologics-usa-2024/
LOCATION:San Diego Convention Center\, 111 West Harbor Drive\, San Diego\, CA 92101\, 92101\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240415
DTEND;VALUE=DATE:20240420
DTSTAMP:20240203T045853Z
CREATED:20240203T045751Z
LAST-MODIFIED:20240203T045853Z
UID:59883-1713139200-1713571199@globalbiodefense.com
SUMMARY:Achieving Data Quality & Integrity In Maximum Containment Laboratories
DESCRIPTION:A FDA-UTMB Collaborative Education Program on Achieving Data Quality & Integrity In Maximum Containment Laboratories Non-Clinical Course will be held 15-19 April 2024 in Galveston\, Texas and online. \nThe four and one-half day training program is offered annually utilizing expert faculty from the U.S. Food and Drug Administration\, other government agencies\, academia\, and business and industry. In-person attendees participate in laboratory activities conducted in mock Biosafety Level (BSL) 2\, 3\, and 4 training laboratories to emphasize the differences between biosafety levels and the complexity of conducting laboratory activities in a BSL4 laboratory environment. \nThe Nonclinical Course includes expert faculty from AAALAC\, BARDA\, Battelle\, CEPI\, FDA\, NIAID\, NIH\, MRI Global\, Pfizer\, Texas Biomedical Research Institute\, UK Health Security Agency\, USAMRIID\, USDA\, UTMB\, Yale University School of Medicine and other institutions. \nHighlighted topics include: \n\nClinical Research at the Ebola Virus Disease Bedside\nApplying One Health Principles for Outbreak Response\nRegulatory Mechanisms to Facilitate Development/Approval/Licensure of Medical Countermeasures\nLife in a BSL-4 Suit\nDevelopment\, Characterization and Standardization of Bacterial and Viral Stocks\nAnimal Models for COVID\nAnimal Rule and Product Development\nData Standards for Animal Rule Studies\nOperationalizing BSL-4 in the Field\nPivotal Studies for NIAID Sponsored Animal Model Development\nQuality System Expectations for BARDA-sponsored studies\nQuality Assurance Auditing in BSL-4 laboratories\nUnforeseen Circumstances: Emergency Response in BSL-4 Laboratories\nAerosol Systems – Aerobiology with High Containment\nThe Role of the USDA National Bio and Agro-Defense Facility (NBAF)\nPublic Health Emergencies and Data Quality: Your Data Can Save Lives\nConducting Clinical Research in the Setting of an Outbreak: From HIV to Ebola to COVID-19\nInteractive Exercises in a Mock BSL-4 Training Laboratory\nBSL-4 Lab Tour\n\nThere are no fees associated with course attendance; however\, seating for in-person attendance is limited and interested participants will be placed on a wait-list once seats are filled. \nPlease visit UTMB’s Achieving Data Quality & Integrity In Maximum Containment Laboratories course page for more information and to register to attend.
URL:https://globalbiodefense.com/event/achieving-data-quality-integrity-in-maximum-containment-laboratories/
LOCATION:UTMB Health Education Center\, 301 11th St\, Galveston\, TX\, 77550\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240416
DTEND;VALUE=DATE:20240420
DTSTAMP:20240207T001036Z
CREATED:20240207T001036Z
LAST-MODIFIED:20240207T001036Z
UID:59938-1713225600-1713571199@globalbiodefense.com
SUMMARY:SHEA Spring Conference 2024
DESCRIPTION:The Society for Healthcare Epidemiology of America SHEA Spring Conference will take place 16-19 April 2024 in Houston\, Texas. \nSHEA members and non-members of all disciplines relating to Infection Prevention Programs\, Antibiotic Stewardship Programs\, Public Health\, Pharmacy\, Occupational Health\, Clinical Microbiology\, Quality Improvement\, and Patient Safety. If you are involved in infection prevention or infection control you should attend. \nHighlighted topics and sessions include: \n\nHow to design stewardship interventions and publish your results\nMicro 101 for the antimicrobial steward\nOverview of resources available for those new to healthcare epidemiology\nPKPD for the antimicrobial stewardship to the C-Suite\nMastering data visualization for antibiotic stewardship and healthcare epidemiology\nOne Health: People\, places and microbes\nResistant pathogens: gram-negative\, C. auris\nPromoting pharmacoequity in antimicrobial stewardship\nTransmission of infectious agents in healthcare\nTo certify or not to certify\, that is the question for healthcare epidemiologists\nCase studies in pediatric infection control\nInfection prevention in special outpatient settings\nStewardship collaboration with public health\nThe hospital epidemiologist as a clinical educator\nUtilizing next generation sequencing in healthcare epidemiology: public health and outbreak investigations\nIncorporating rapid diagnostics and biomarkers into stewardship interventions\n\nPlease visit the SHEA Spring Conference website for more information and to register to attend.
URL:https://globalbiodefense.com/event/shea-spring-conference-2024/
LOCATION:Westin Galleria Houston\, 5060 W Alabama St\, Houston\, TX\, 77056\, United States
ORGANIZER;CN="The Society for Healthcare Epidemiology of America (SHEA)":MAILTO:info@shea-online.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240418T110000
DTEND;TZID=America/New_York:20240418T120000
DTSTAMP:20240330T183242Z
CREATED:20240330T183242Z
LAST-MODIFIED:20240330T183242Z
UID:60731-1713438000-1713441600@globalbiodefense.com
SUMMARY:Patch Forward Prize Virtual Information Session
DESCRIPTION:Learn more about the Patch Forward Prize and ask questions at the April 18 virtual information session. \nThe Patch Forward Prize is a $50 million competition to advance microneedle patch-based RNA vaccines for COVID-19\, seasonal influenza\, and pandemic influenza. The Biomedical Advanced Research and Development Authority (BARDA) calls on vaccine developers and patch makers to partner and accelerate new vaccine technologies. \nDr. Robert Johnson\, Director of BARDA’s Medical Countermeasures Program\, will discuss the ambitious goals for the prize. The prize team will also present an in-depth overview of the three stages\, exploring submission expectations\, eligibility requirements\, and other key considerations. \nA video recording and summary of questions and answers will be published following the session. \nPlease visit BARDA’s Patch Forward Prize Virtual Information Session page to register.
URL:https://globalbiodefense.com/event/patch-forward-prize-virtual-information-session/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240421
DTEND;VALUE=DATE:20240425
DTSTAMP:20240207T030149Z
CREATED:20240207T030124Z
LAST-MODIFIED:20240207T030149Z
UID:59942-1713657600-1714003199@globalbiodefense.com
SUMMARY:2024 mRNA Technology Conference
DESCRIPTION:The 2024 mRNA Technology Conference will be held 21-24 April 2024 in Boston\, Massachusetts. \nThe event will showcase never before presented research and technology advances from both established leaders and early career professionals providing insights into present\, developing\, and future mRNA Applications. \nHighlighted program sessions include: \n\nManufacturing: IVT Process Optimization and Reactors Design\nAnalytical Characterization of mRNA\nOptimization & Design of mRNA for Future Therapeutics\n\nPlease visit AIChE’s 2024 mRNA Technology Conference website for more information.
URL:https://globalbiodefense.com/event/2024-mrna-technology-conference/
LOCATION:Revere Hotel Boston Common\, 200 Stuart St.\, Boston\, MA\, 02116\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240421
DTEND;VALUE=DATE:20240426
DTSTAMP:20240303T174832Z
CREATED:20240303T174832Z
LAST-MODIFIED:20240303T174832Z
UID:60502-1713657600-1714089599@globalbiodefense.com
SUMMARY:Chemical\, Biological\, Radiological\, Nuclear\, and Explosives (CBRNE) Sensing XXV
DESCRIPTION:SPIE’s Chemical\, Biological\, Radiological\, Nuclear\, and Explosives (CBRNE) Sensing XXV Conference will be held 22-25 April 2024 in National Harbor\, Maryland. \nThis conference provides an unprecedented forum for authors from government\, industry\, and academia to address a wide variety of CBRNE sensing issues\, technologies\, and advances in algorithms and signal process of threat related scenarios. \nThe sensing of CBRNE hazards is important to obtain “real-time” answers that allow actionable decisions to be made on-the-spot; to reduce the logistical burden by moving the analysis closer to the source of the sample; to rapidly screen materials to identify samples that need to be sent to a lab for additional analysis while minimizing the number of these samples; and to nondestructively analyze large\, valuable\, or immovable objects for which sampling is not possible. \nFurthermore\, defense communities around the world are increasingly interested in offloading forward decision making and analysis from soldiers to software\, which increases the need for more robust and accurate signal processing development to enable greater trust in detection outputs as the trend towards autonomous sensing continues. A strong reliance of CBRNE forensics is also required to enable attribution of these threats\, ideally in situ. In addition to protecting against battlefield CBRNE threats\, there is an increasing demand to protect borders and ports from the emergent threats of improvised explosive devices (IEDs)\, homemade explosives (HMEs)\, nuclear devices\, radiological dispersal devices\, and illicit narcotics. New and sophisticated radiation detection systems are also required for better protection of military personnel and civilians from radiological threats. \nAll of these sensor technologies are supported by advances in algorithms for sensor signal and data processing\, including sensor fusion\, machine learning/artificial intelligence. \nHighlighted topics include: \n\nBiothreat detection and identification using a carbon nanotube capture and containment array and surface enhanced Raman spectroscopy\nRapid detection of bioaerosol by measuring single particle differential circular polarization scattering (CIDS)\nCondensation-based growth of nanoparticles for real-time inertial-based capture and biothreat sensing\nBiolayer interferometry as a biological detection platform\nDetection of microorganisms in drinking water using fluorescence spectroscopy\nOptical constants measurements of liquids for modeling aerosolized threats\nAerosol release tracking via optical barcodes: aerosol sensor testing ground truth\nAerosol mass spectrometer for aerosol characterization at the ambient aerosol test facility\nEvaluation of emerging sensors to detect chemical exposure for food protection\nImproving Raman stand-off distance for the detection of chemical warfare agents\n\nConference Committee Members include: \n\nJason A. Guicheteau\, DEVCOM Chemical Biological Ctr\nChristopher R. Howle\, Defence Science and Technology Lab\nTanya L. Myers\, Pacific Northwest National Lab\nChristopher C. Carter\, Johns Hopkins Univ. Applied Physics Lab.\, LLC\nAugustus W. Fountain\, Univ. of South Carolina\nTimothy J. Johnson\, Pacific Northwest National Lab\nLars Landström\, FOI-Swedish Defence Research Agency\nAaron LaPointe\, U.S. Army CCDC C5ISR Ctr. Night Vision & Electronic Sensors Directorate\nTyler Miller\, Defense Threat Reduction Agency\nPaul M. Pellegrino\, DEVCOM Army Research Lab.\nSherrie S. Pilkington\, Intelligence Advanced Research Projects Activity\nNathaniel R. Gomer\, The Pennsylvania State Univ.\n\nThe conference track is part of the larger SPIE Defense + Commercial Sensing 2024 event. Please visit the Chemical\, Biological\, Radiological\, Nuclear\, and Explosives (CBRNE) Sensing XXV website for more information.
URL:https://globalbiodefense.com/event/chemical-biological-radiological-nuclear-and-explosives-cbrne-sensing-xxv/
LOCATION:Gaylord National Resort and Convention Center\, 201 Waterfront Street\, National Harbor\, MD\, 20745\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240422
DTEND;VALUE=DATE:20240425
DTSTAMP:20240218T231853Z
CREATED:20240218T231748Z
LAST-MODIFIED:20240218T231853Z
UID:60050-1713744000-1714003199@globalbiodefense.com
SUMMARY:Iraq Rapid Inactivation of High Consequence Pathogens Workshop
DESCRIPTION:On behalf of the US Defense Threat Reduction Agency (DTRA)\, Sandia National Laboratories will host “Developing Laboratory Best Practices for Rapid Inactivation of High Consequences Pathogens and Sensitive Equipment Workshop” in April 2024. Stakeholders from Central Veterinary Laboratories (CVL) and Central Public Health Laboratories (CPHL) from the Government of Iraq (GOI) and Iraqi Kurdistan Region (IKR) who work with high consequence pathogens will attend to develop a long-term sample life cycle management plan. \nThis Cooperative Threat Reduction (CTR) initiative will be held in Istanbul from 22 April to 24 April. \nThis training will consist of three Phases: \nPhase I will consist of virtual sessions with institutions before and after the training event to review their laboratory’s current sample retention practices\, decontamination methods and efficacy\, discuss cost considerations for sustainability\, and work to review and draft standardized standard operation procedures (SOPs) on the destruction and disposal of the laboratory’ pathogen repository and sensitive equipment. \nPhase II will consist of a three-day workshop held in April 2024\, in Istanbul\, Turkey. Phase II topics will include rapid inactivation/destruction of pathogens and sensitive equipment\, the role of material control and accountability in biosecurity\, different types of administrative controls with a focus on biorisk management (BRM) documentation\, sample inventory system components\, the process of effective planning for reaching institutional BRM goals\, and finally how to safeguard laboratory pathogens. \nPhase III will consist of a virtual session where SNL/GCBS will facilitate Iraqi mentors identified from CVL and CPHL target laboratories in Bagdad and Erbil in conducting a virtual “Regional Rapid Inactivation Best Practices Training” for additional nominated participants from regional animal and public health laboratories to review the final developed practices\, policies\, and standard operating procedures (SOPs) for sample life cycle and rapid inactivation of high consequence pathogens and sensitive equipment management plan. \nLearn more and by visiting the Sandia’s Global Chemical and Biological Security Events page or contacting contact Sarah Calcutt.
URL:https://globalbiodefense.com/event/iraq-rapid-inactivation-of-high-consequence-pathogens-workshop/
LOCATION:Istanbul\, Istanbul\, Turkey
END:VEVENT
END:VCALENDAR